Guild Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-762
Closed -$249K 49
2025
Q4
$249K Hold
762
0.18% 41
2025
Q3
$215K Hold
762
0.17% 45
2025
Q2
$213K Hold
762
0.18% 42
2025
Q1
$237K Buy
+762
New +$225K 0.25% 39
2024
Q4
Sell
-762
Closed -$246K 39
2024
Q3
$246K Hold
762
0.27% 38
2024
Q2
$238K Hold
762
0.27% 45
2024
Q1
$217K Hold
762
0.28% 45
2023
Q4
$219K Hold
762
0.35% 43
2023
Q3
$205K Buy
+762
New +$190K 0.34% 49
2023
Q1
Sell
-762
Closed -$200K 56
2022
Q4
$200K Buy
+762
New +$204K 0.34% 49
2021
Q3
Sell
-831
Closed -$203K 73
2021
Q2
$203K Buy
831
+9
+1% +$2.21K 0.2% 64
2021
Q1
$205K Buy
+822
New +$196K 0.22% 67

Other funds holding AMGN

Guild Investment Management's AMGN Position: Q1 2026 in Review

Guild Investment Management sold out of Amgen (AMGN) in Q1 2026, closing a stake of 762 shares — an estimated $249K sold.

Guild Investment Management first reported a position in AMGN in Q1 2021 and held it in 12 quarters. The position peaked at $249K in Q4 2025. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Guild Investment Management reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Guild Investment Management sold 762 Amgen shares in Q1 2026, an estimated $249K.
  • Guild Investment Management first reported a position in Amgen in Q1 2021 and held it in 12 quarters.
  • Guild Investment Management's Amgen position peaked at $249K in Q4 2025.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Guild Investment Management's 13F filing for Q1 2026, filed 20 Apr 2026.